Results
|
68301.
|
|
|
68302.
|
|
|
68303.
|
|
|
68304.
|
|
|
68305.
|
|
|
68306.
|
|
|
68307.
|
|
|
68308.
|
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial. [electronic resource] by
- Gregorc, Vanesa
- Novello, Silvia
- Lazzari, Chiara
- Barni, Sandro
- Aieta, Michele
- Mencoboni, Manlio
- Grossi, Francesco
- De Pas, Tommaso
- de Marinis, Filippo
- Bearz, Alessandra
- Floriani, Irene
- Torri, Valter
- Bulotta, Alessandra
- Cattaneo, Angela
- Grigorieva, Julia
- Tsypin, Maxim
- Roder, Joanna
- Doglioni, Claudio
- Levra, Matteo Giaj
- Petrelli, Fausto
- Foti, Silvia
- Viganò, Mariagrazia
- Bachi, Angela
- Roder, Heinrich
Producer: 20140730
In:
The Lancet. Oncology vol. 15
Availability: No items available.
|
|
68309.
|
|
|
68310.
|
|
|
68311.
|
|
|
68312.
|
|
|
68313.
|
|
|
68314.
|
|
|
68315.
|
|
|
68316.
|
|
|
68317.
|
|
|
68318.
|
|
|
68319.
|
|
|
68320.
|
|